The final trading weeks of 2025 are witnessing a classic “Santa Rally” with a futuristic twist. Institutional desks have thinned out for the holiday season—the proverbial “smart money” taking a breather— and retail investors are driving a surge in quantum stocks.QBTS stock is soaring. See the chart and price action here. The Retail-Fueled MomentumThe “diamond hands” crowd has rotated into high-beta quantum stocks names. fueled by a series of strategic year-end milestones and bullish analyst coverage from Je ...

Key Points This quantum computing stock is up triple-digit percentage points in 2025, but it could keep climbing in 2026. Strong sales momentum is pushing the stock higher, as it attracts dozens of new customers with longer contract terms. The stock remains highly speculative, but its commercial sales make it less so than other quantum computing stocks. 10 stocks we like better than D-Wave Quantum › Advancements in the technologies used for quantum computing over the last few years have led inve ...

Key Points Quantum computing stocks in general outperformed the market in 2025. IonQ stock in particular barely kept pace with the S&P 500. 10 stocks we like better than IonQ › Shares of quantum computing company IonQ (NYSE: IONQ) soared 10% through 11:25 a.m. ET Monday. And why? That's not entirely clear. So far as I can tell, there's no significant quantum stock news concerning either IonQ stock in particular or quantum stocks in general today. Investor's Business Daily does have a story out, bu ...

SHENZHEN, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, launched a brand-new FPGA-based quantum computing simulation framework founded on a serial-parallel architecture. This framework adopts an innovative hardware-level data path design and, by redefining the execution mode of quantum gate operations, achieves a linear reduction in resource utilization. This framework not only demonstrates the inherent advantages ...

Key Points Quantum computing stocks, plural, have done very well in 2025. Quantum Computing stock, singular, has not. 10 stocks we like better than Quantum Computing › Shares of eponymous quantum computing company Quantum Computing Inc. (NASDAQ: QUBT) soared 11.6% through 11 a.m. ET Monday. And why? That's not entirely clear. There's no significant quantum stock news out today, concerning either Quantum Computing stock in particular or quantum stocks in general. There is a story on Investor's Busi ...

Key Points D-Wave Quantum stock more than tripled this year. The company plans to present its technology at CES 2026 in January. 10 stocks we like better than D-Wave Quantum › Shares of quantum computing company D-Wave Quantum Inc. (NYSE: QBTS) soared 13.5% through 10:40 a.m. ET Monday. And why? This morning the company announced it will participate in CES 2026 on Jan. 7, 2026, presenting there "its award-winning annealing quantum computing technology, hybrid quantum-classical solvers, and real-wo ...

智通财经APP获悉，周一，美股量子计算概念股拉升，截至发稿，D-Wave Quantum(QBTS.US)涨超 14%，Quantum Computing(QUBT.US)涨超10%，IonQ Inc(IONQ.US)涨超8.5%，Rigetti Computing(RGTI.US)涨超10%，Arqit Quantum(ARQQ.US)涨超7%，SEALSQ Corp(LAES.US)涨超11%。 ...

Core Insights - Quantum computing stocks gained significant attention in 2025, with Rigetti Computing set to outperform IonQ, achieving a year-to-date gain of nearly 50% compared to IonQ's 15% [1] Company Analysis: IonQ - IonQ's potential advantage lies in its trapped-ion technology, utilizing actual ytterbium and barium atoms, which are more stable and can lead to fewer errors in quantum computing [4] - The company aims to build a comprehensive quantum computing ecosystem, similar to Nvidia's approach in AI infrastructure, by making aggressive acquisitions in quantum sensing, interconnect, satellite, and semiconductor technology [5] - IonQ has a strong financial position with a significant cash reserve to fund research and development, and its revenue grew over 200% in Q3, reaching nearly $40 million [6] Company Analysis: Rigetti Computing - Rigetti's technology is noted for being faster than IonQ's but is also more error-prone, indicating a trade-off between speed and reliability in their quantum computing solutions [7]

Core Viewpoint - Viewbix Inc. is set to acquire Quantum X Labs, which has developed a groundbreaking quantum computing technology that enhances clinical trial methodologies, potentially transforming the pharmaceutical and drug discovery markets [4][5]. Group 1: Acquisition Details - Viewbix has signed a definitive agreement to acquire up to 100% (and not less than 85%) of Quantum X Labs, which includes its expanding patent portfolio [5]. - The acquisition is expected to close within 90 days from December 15, 2025, pending due diligence and regulatory approvals [5]. Group 2: Technological Advancements - Quantum X Labs has filed a provisional patent for a technology that improves Markov Chain Monte Carlo methods using quantum computing, allowing for more efficient sampling from complex probability distributions [2]. - The new methodology aims to reveal hidden biological structures and dependencies in clinical data, enabling better identification of patient clusters and treatment responses with potentially fewer samples than traditional methods [3]. Group 3: Market Implications - The advancements from Quantum X Labs could convert underpowered clinical trial datasets into robust mechanistic evidence, enhancing the success rates of personalized medicine [4]. - As quantum computing technology matures, it positions Viewbix to capture significant value in the pharmaceutical sector by reducing trial costs and timelines [4].

Group 1 - Pure-play quantum computing stocks gained significant attention from Wall Street in 2025 as major financial institutions initiated coverage on several companies [1] - Heading into 2026, IonQ (IONQ) and D-Wave Quantum (QBTS) received the most buy ratings and the highest average price targets from Wall Street analysts [1] - Rigetti Computing (RGTI) is receiving mixed reviews from analysts, indicating a less favorable outlook compared to its peers [1]